Skip to main content
Top

Cancer Causes & Control

Issue 8/2004

Content (12 Articles)

Occupation and Bladder Cancer Risk in a Population-based Case-control Study in New Hampshire

Joanne S. Colt, Dalsu Baris, Patricia Stewart, Alan R. Schned, John A. Heaney, Leila A. Mott, Debra Silverman, Margaret Karagas

Tobacco and Alcohol Consumption and the Risk of Non-Hodgkin Lymphoma

Eleanor V Willett, Alexandra G. Smith, Gareth J. Dovey, Gareth J. Morgan, Jan Parker, Eve Roman

Cataract Extraction and Risk of Breast Cancer

Shumin M. Zhang, Walter C. Willett, Frank B. Hu, Edward L. Giovannucci, JoAnn E. Manson, Graham A. Colditz, Susan E. Hankinson

Dietary Determinants of Circulating Insulin-like Growth Factor (IGF)-I and IGF Binding Proteins 1, -2 and -3 in Women in the Netherlands

Alina Vrieling, Dorien W. Voskuil, H. Bas Bueno de Mesquita, Rudolf Kaaks, Paul A.H. van Noord, Lital Keinan-Boker, Carla H. van Gils, Petra H.M. Peeters

Cigarette Smoking Among Lesbians, Gays, and Bisexuals: How Serious a Problem? (United States)

Hao Tang, Greg L. Greenwood, David W. Cowling, Jon C. Lloyd, April G. Roeseler, Dileep G. Bal

Phyto-oestrogen Intake and Breast Cancer Risk in South Asian Women in England: Findings from a Population-based Case-Control Study

Isabel dos Santos Silva, Punam Mangtani, Valerie McCormack, Dee Bhakta, Anthony J McMichael, Leena Sevak

Prior Lung Disease and Risk of Lung Cancer in a Large Prospective Study

Alyson J. Littman, Mark D. Thornquist, Emily White, Lisa A. Jackson, Gary E. Goodman, Thomas L. Vaughan

Twinning and the Incidence of Breast and Gynecological Cancers (United States)

Rachel E. Neale, David M. Purdie, Michael F. G. Murphy, Geraldine P. Mineau, Timothy Bishop, David C. Whiteman

HBV Infection and Familial Aggregation of Liver Cancer: An Analysis of Case-Control Family Study

Yanhui Gao, Qingwu Jiang, Xuefu Zhou, Baoguo Ding, Ruhong Wang, Genming Zhao, Yue Chen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine